Systematic Review

Published on 07 Nov 2024

Efficacy and safety of Toliparibumab for the treatment of non-small cell lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Yihao Liu
Liangyu Yang
Zhixuan Duan
Qian Cheng
Minghui Liu
HongBing Zhang
HongLin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1444312

570 views

Case Report

Published on 07 Nov 2024

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression

in Thoracic Oncology

Shuo Wu
Changhong Dong
Chenxi Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437260

501 views

Original Research

Accepted on 06 Nov 2024

Application of Disitamab vedotin in the Multiline Treatment of EGFR Mutation-Positive Lung Adenocarcinoma with Her-2 Overexpression

in Thoracic Oncology

Meiling Lan
Tianyun Wang
Diexiao Luo
Yan Chen
Wei Liang
Rui Kong
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1472545

Original Research

Published on 04 Nov 2024

The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis

in Thoracic Oncology

Zhenghua Cao
Shengkun Zhao
Tong Wu
Huan Ding
Zhiyu Tian
Feng Sun
Zhuo Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1438851

631 views

Editorial

Published on 04 Nov 2024

Editorial: Innovative strategies and new insights for the treatment of stage III non-small cell lung cancer

in Thoracic Oncology

Francesco Cortiula
Aakash Desai
Jessica Menis
Andrea R. Filippi

Frontiers in Oncology

doi 10.3389/fonc.2024.1503613

409 views

Original Research

Published on 04 Nov 2024

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

in Thoracic Oncology

Anna Tanaka
Shuhei Teranishi
Yukihito Kajita
Tomofumi Hirose
Ayami Kaneko
Yu Sairenji
Hidetoshi Kawashima
Kentaro Yumoto
Toshinori Tsukahara
Kenji Miura

Frontiers in Oncology

doi 10.3389/fonc.2024.1400277

696 views

Mini Review

Published on 01 Nov 2024

Exercise’s impact on lung cancer molecular mechanisms: a current overview

in Thoracic Oncology

Annamaria Mancini
Francesca Maria Orlandella
Daniela Vitucci
Neila Luciano
Andreina Alfieri
Stefania Orrù
Giuliana Salvatore
Pasqualina Buono

Frontiers in Oncology

doi 10.3389/fonc.2024.1479454

557 views

Case Report

Published on 01 Nov 2024

Therapeutic strategies to overcome ALK-fusion and BRAF-mutation as acquired resistance mechanism in EGFR-mutated non-small cell lung cancer: two case reports

in Thoracic Oncology

Yuan Zeng
Qiang Zeng
Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390523

650 views

Editorial

Published on 31 Oct 2024

Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC

in Thoracic Oncology

Paola Ulivi

Frontiers in Oncology

doi 10.3389/fonc.2024.1506160

483 views

Case Report

Published on 31 Oct 2024

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer—a case series of divergent results from a large reference laboratory

in Thoracic Oncology

Kyle C. Strickland
Mary K. Nesline
Rebecca A. Previs
Heidi Ko
Maureen Cooper
Jennifer R. Rushton
Zachary D. Wallen
Sarabjot Pabla
Jeffrey M. Conroy
Mark Sausen

Frontiers in Oncology

doi 10.3389/fonc.2024.1445668

681 views

Original Research

Published on 30 Oct 2024

The value of multiple diffusion metrics based on whole-lesion histogram analysis in evaluating the subtypes and proliferation status of non-small cell lung cancer

in Thoracic Oncology

Yao Chen
Hong Yang
Yuan Qin
Chuanjiang Guan
Wenbing Zeng
Yong Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1434326

408 views

Editorial

Accepted on 29 Oct 2024

Editorial: KRAS in Stage IV Non-Small Cell Lung Cancer

in Thoracic Oncology

Anneloes L. Noordhof
Torsten Gerriet Blum
Georgia Hardavella
Lizza E.L. Hendriks
Wouter H. Van Geffen

Frontiers in Oncology

doi 10.3389/fonc.2024.1517049

Case Report

Published on 29 Oct 2024

Primary hepatoid adenocarcinoma of the lung in patient with silicosis: a case report and literature review

in Thoracic Oncology

Lipeng Huang
Chaoyang Chen
Qingyu Sun
Zhichen Yu
Xiaoyan Wang
Xinle Wang
Shuoqi Yang
Luming Jin
Liang Bu

Frontiers in Oncology

doi 10.3389/fonc.2024.1380717

379 views

Review

Published on 29 Oct 2024

Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research

in Thoracic Oncology

Parth J. Sampat
Alyssa Cortese
Alexandra Goodman
Ghanshyam H. Ghelani
Michael D. Mix
Stephen Graziano
Alina Basnet

Frontiers in Oncology

doi 10.3389/fonc.2024.1411432

709 views

Correction

Published on 28 Oct 2024

Corrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system

in Thoracic Oncology

Hyunjong Lee
Kyung Soo Lee
Yang Won Min
Hong Kwan Kim
Jae Ill Zo
Young Mog Shim
Joon Young Choi

Frontiers in Oncology

doi 10.3389/fonc.2024.1505996

277 views

Systematic Review

Published on 25 Oct 2024

Worldwide research trends on bone metastases of lung cancer: a bibliometric analysis

in Thoracic Oncology

Zhongying Rui
Dongyan Lu
Lijuan Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1429194

469 views

Navigation group

Articles

Efficacy and safety of Toliparibumab for the treatment of non-small cell lung cancer: a systematic review and meta-analysis

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression

Application of Disitamab vedotin in the Multiline Treatment of EGFR Mutation-Positive Lung Adenocarcinoma with Her-2 Overexpression

The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis

Editorial: Innovative strategies and new insights for the treatment of stage III non-small cell lung cancer

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

Exercise’s impact on lung cancer molecular mechanisms: a current overview

Therapeutic strategies to overcome ALK-fusion and BRAF-mutation as acquired resistance mechanism in EGFR-mutated non-small cell lung cancer: two case reports

Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer—a case series of divergent results from a large reference laboratory

The value of multiple diffusion metrics based on whole-lesion histogram analysis in evaluating the subtypes and proliferation status of non-small cell lung cancer

Editorial: KRAS in Stage IV Non-Small Cell Lung Cancer

Primary hepatoid adenocarcinoma of the lung in patient with silicosis: a case report and literature review

Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research

Corrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system

Worldwide research trends on bone metastases of lung cancer: a bibliometric analysis